| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 4.75e-06 | 4 | 213 | 3 | GO:0003873 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 1.18e-05 | 5 | 213 | 3 | GO:0004331 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.69e-05 | 17 | 213 | 4 | GO:0022848 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 4.06e-05 | 7 | 213 | 3 | GO:0008443 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF136 ZNF627 ZNF613 ETV6 SOX8 ZNF840P ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 POU4F3 PASD1 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 MYB PROP1 ZNF554 ZNF124 | 7.81e-05 | 1459 | 213 | 32 | GO:0000977 |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 9.12e-05 | 43 | 213 | 5 | GO:0005231 | |
| GeneOntologyMolecularFunction | sugar-phosphatase activity | 1.36e-04 | 10 | 213 | 3 | GO:0050308 | |
| GeneOntologyMolecularFunction | carbohydrate phosphatase activity | 1.85e-04 | 11 | 213 | 3 | GO:0019203 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.11e-04 | 28 | 213 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF136 ZNF627 ETV6 SOX8 ZNF840P ZNF461 ZNF878 ZNF556 ZNF615 ZNF844 ZNF560 ZNF670 POU4F3 PASD1 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 MYB PROP1 ZNF554 ZNF124 | 2.32e-04 | 1412 | 213 | 30 | GO:0000981 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KATNAL2 SPAST TDRD9 CFTR BCS1L STARD9 ACSF3 DNAH6 DNHD1 DNAH10 CHD9 CHD8 ABCA5 CHD5 AACS DHX34 TOP2A | 3.32e-04 | 614 | 213 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.31e-04 | 37 | 213 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.47e-04 | 65 | 213 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.47e-04 | 65 | 213 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.68e-04 | 18 | 213 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.12e-03 | 193 | 213 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.28e-03 | 197 | 213 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 1.38e-03 | 21 | 213 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.40e-03 | 77 | 213 | 5 | GO:0005230 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 3.08e-05 | 18 | 217 | 4 | GO:0005892 | |
| GeneOntologyCellularComponent | cholinergic synapse | 7.13e-05 | 22 | 217 | 4 | GO:0098981 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.25e-04 | 10 | 217 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | microtubule | KATNAL2 SPAST IQGAP2 MAP6 CKAP5 DST EML5 KLHL21 ASPM DNAH6 DNAH10 SHROOM2 OPA1 HOOK3 EIF3A ARHGAP18 | 1.51e-04 | 533 | 217 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | cell leading edge | IQGAP2 MCC ITGB3 CHRNA7 DST NF2 PTPRM NHS ADAM17 PLD2 CACNA1D STON1 ANK1 MTMR6 ARHGAP18 | 2.44e-04 | 500 | 217 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | postsynapse | USP9X SLC6A17 ZZEF1 BCR ITGB3 CHRNA4 CHRNA7 NEDD4 VPS52 DST GRK3 MTMR2 ARC CHRNA10 CACNA1S LRFN1 ANK1 CHRNA9 MINK1 GLRA3 LAMA2 AKAP9 EIF3A | 3.96e-04 | 1018 | 217 | 23 | GO:0098794 |
| Domain | KRAB | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 4.99e-12 | 358 | 217 | 24 | PS50805 |
| Domain | KRAB | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 4.99e-12 | 358 | 217 | 24 | PF01352 |
| Domain | KRAB | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 9.46e-12 | 369 | 217 | 24 | SM00349 |
| Domain | KRAB | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 1.00e-11 | 370 | 217 | 24 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF12 ZNF20 ZNF382 ZNF727 ZNF75A ZNF439 ZNF554 | 2.99e-08 | 314 | 217 | 18 | PF13912 |
| Domain | zf-C2H2 | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 5.37e-07 | 693 | 217 | 25 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 5.52e-07 | 694 | 217 | 25 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 ZNF804B RBAK ZNF727 ZNF75A ZNF350 ZNF439 DHX34 ZNF583 ZNF554 ZNF124 | 6.09e-07 | 796 | 217 | 27 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 ZNF804B RBAK ZNF727 ZNF75A ZNF350 ZNF439 DHX34 ZNF583 ZNF554 ZNF124 | 8.13e-07 | 808 | 217 | 27 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 ZNF804B RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 1.23e-06 | 775 | 217 | 26 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 ZNF804B RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 1.29e-06 | 777 | 217 | 26 | PS00028 |
| Domain | - | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF665 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 1.32e-06 | 679 | 217 | 24 | 3.30.160.60 |
| Domain | Znf_C2H2 | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF665 ZNF382 ZNF804B RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 2.47e-06 | 805 | 217 | 26 | IPR007087 |
| Domain | 6Phosfructo_kin | 6.13e-06 | 4 | 217 | 3 | IPR013079 | |
| Domain | 6Pfruct_kin | 6.13e-06 | 4 | 217 | 3 | IPR003094 | |
| Domain | 6PF2K | 6.13e-06 | 4 | 217 | 3 | PF01591 | |
| Domain | P-loop_NTPase | N4BP2L1 KATNAL2 SPAST TDRD9 CFTR PFKFB1 PFKFB2 PFKFB3 BCS1L SAMD9L NOD1 STARD9 RAB30 ASPM GNA12 DNAH6 DNHD1 DNAH10 NDST2 CHD9 CHD8 OPA1 CASK ABCA5 CHD5 DHX34 | 6.31e-06 | 848 | 217 | 26 | IPR027417 |
| Domain | - | N4BP2L1 KATNAL2 SPAST TDRD9 CFTR PFKFB1 PFKFB2 PFKFB3 BCS1L SAMD9L NOD1 RAB30 GNA12 DNAH6 DNHD1 DNAH10 NDST2 CHD9 CHD8 OPA1 CASK ABCA5 CHD5 DHX34 | 6.62e-06 | 746 | 217 | 24 | 3.40.50.300 |
| Domain | Nicotinic_acetylcholine_rcpt | 2.89e-05 | 16 | 217 | 4 | IPR002394 | |
| Domain | PG/BPGM_mutase_AS | 1.23e-04 | 9 | 217 | 3 | IPR001345 | |
| Domain | - | 1.32e-04 | 23 | 217 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 1.32e-04 | 23 | 217 | 4 | IPR027361 | |
| Domain | NHS | 1.34e-04 | 2 | 217 | 2 | PF15273 | |
| Domain | NHS_fam | 1.34e-04 | 2 | 217 | 2 | IPR024845 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.69e-04 | 45 | 217 | 5 | IPR018000 | |
| Domain | PGAM | 1.75e-04 | 10 | 217 | 3 | SM00855 | |
| Domain | PG_MUTASE | 1.75e-04 | 10 | 217 | 3 | PS00175 | |
| Domain | Neur_chan_memb | 1.88e-04 | 46 | 217 | 5 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 2.08e-04 | 47 | 217 | 5 | IPR006029 | |
| Domain | - | 2.08e-04 | 47 | 217 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 2.08e-04 | 47 | 217 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 2.08e-04 | 47 | 217 | 5 | PS00236 | |
| Domain | Neur_channel | 2.08e-04 | 47 | 217 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.08e-04 | 47 | 217 | 5 | IPR006202 | |
| Domain | His_Pase_superF_clade-1 | 3.15e-04 | 12 | 217 | 3 | IPR013078 | |
| Domain | His_Phos_1 | 3.15e-04 | 12 | 217 | 3 | PF00300 | |
| Domain | Dynein_HC_stalk | 5.12e-04 | 14 | 217 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.12e-04 | 14 | 217 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.12e-04 | 14 | 217 | 3 | PF08393 | |
| Domain | TUDOR | 5.12e-04 | 14 | 217 | 3 | PF00567 | |
| Domain | MT | 5.12e-04 | 14 | 217 | 3 | PF12777 | |
| Domain | DHC_fam | 6.35e-04 | 15 | 217 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 6.35e-04 | 15 | 217 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.35e-04 | 15 | 217 | 3 | IPR004273 | |
| Domain | Asp/Asn-tRNA-synth_IIb | 7.94e-04 | 4 | 217 | 2 | IPR002312 | |
| Domain | FAM86 | 7.94e-04 | 4 | 217 | 2 | IPR029426 | |
| Domain | VDCC_L_a1su | 7.94e-04 | 4 | 217 | 2 | IPR005446 | |
| Domain | FAM86 | 7.94e-04 | 4 | 217 | 2 | PF14904 | |
| Domain | aa-tRNA-synt_II | 1.31e-03 | 5 | 217 | 2 | IPR004364 | |
| Domain | tRNA-synt_2 | 1.31e-03 | 5 | 217 | 2 | PF00152 | |
| Domain | Na/ntran_symport_orphan | 1.31e-03 | 5 | 217 | 2 | IPR002438 | |
| Domain | aa-tRNA-synt_II-like | 1.31e-03 | 5 | 217 | 2 | IPR018150 | |
| Domain | AAA | 1.49e-03 | 144 | 217 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.49e-03 | 144 | 217 | 7 | IPR003593 | |
| Domain | - | 1.52e-03 | 20 | 217 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 1.52e-03 | 20 | 217 | 3 | IPR029033 | |
| Domain | - | 1.95e-03 | 6 | 217 | 2 | 2.40.50.90 | |
| Domain | BRK | 1.95e-03 | 6 | 217 | 2 | SM00592 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.95e-03 | 6 | 217 | 2 | IPR016071 | |
| Domain | BRK_domain | 1.95e-03 | 6 | 217 | 2 | IPR006576 | |
| Domain | PEROXIDASE_1 | 1.95e-03 | 6 | 217 | 2 | PS00435 | |
| Domain | BRK | 1.95e-03 | 6 | 217 | 2 | PF07533 | |
| Domain | TUDOR | 2.31e-03 | 23 | 217 | 3 | PS50304 | |
| Domain | Chromo_domain | 2.61e-03 | 24 | 217 | 3 | IPR023780 | |
| Domain | PLA2_B | 2.72e-03 | 7 | 217 | 2 | PF01735 | |
| Domain | PLA2C | 2.72e-03 | 7 | 217 | 2 | PS51210 | |
| Domain | Ca_chan_IQ | 2.72e-03 | 7 | 217 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.72e-03 | 7 | 217 | 2 | PF08763 | |
| Domain | ZnF_UBR1 | 2.72e-03 | 7 | 217 | 2 | SM00396 | |
| Domain | LysoPLipase_cat_dom | 2.72e-03 | 7 | 217 | 2 | IPR002642 | |
| Domain | VDCC_a1su_IQ | 2.72e-03 | 7 | 217 | 2 | IPR014873 | |
| Domain | GPHH | 2.72e-03 | 7 | 217 | 2 | PF16905 | |
| Domain | ZF_UBR | 2.72e-03 | 7 | 217 | 2 | PS51157 | |
| Domain | GPHH_dom | 2.72e-03 | 7 | 217 | 2 | IPR031649 | |
| Domain | zf-UBR | 2.72e-03 | 7 | 217 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.72e-03 | 7 | 217 | 2 | IPR003126 | |
| Domain | PLAc | 2.72e-03 | 7 | 217 | 2 | SM00022 | |
| Pubmed | ZNF136 ZNF627 ZNF878 ZNF615 ZNF649 YTHDF2 ZNF670 ZNF563 ZNF20 ZNF583 ZNF554 ZNF124 | 2.01e-09 | 181 | 219 | 12 | 37372979 | |
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 17559419 | ||
| Pubmed | Sources of energy for gating by neurotransmitters in acetylcholine receptor channels. | 1.88e-07 | 9 | 219 | 4 | 22647603 | |
| Pubmed | CCDC8 USP9X STXBP3 NF2 PTPRM MTMR2 NHS NUP107 MINK1 SLC6A15 OPA1 CASK PCF11 NHSL1 PTPDC1 MTMR6 AKAP9 SLTM OTUD4 CSTF3 UBR3 SDF4 CXADR | 2.44e-07 | 1049 | 219 | 23 | 27880917 | |
| Pubmed | CCDC8 DST STXBP3 NF2 PTPRM MTMR2 NHS NEDD4L MINK1 SLC6A15 OPA1 CASK NHSL1 CXADR | 5.42e-07 | 421 | 219 | 14 | 36976175 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SPAST IQGAP2 USP9X VPS52 DST STXBP3 PYGL NEDD4L NUP107 UBR4 DARS2 STRIP1 CASK TOP2A PRPS1 | 7.36e-07 | 498 | 219 | 15 | 36634849 |
| Pubmed | Acetylcholine receptors in the retinas of the α7 nicotinic acetylcholine receptor knockout mouse. | 9.81e-07 | 4 | 219 | 3 | 25352741 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 35431807 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 10095107 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 9464277 | ||
| Pubmed | 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. | 9.81e-07 | 4 | 219 | 3 | 7574501 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 28725182 | ||
| Pubmed | Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice. | 9.81e-07 | 4 | 219 | 3 | 28955208 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 2837207 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | USP9X NARS1 BCS1L STXBP3 AGL PYGL FGG YTHDF2 MPO NUP107 LARS2 DARS2 SND1 EIF3A TOP2A PRPS1 | 1.78e-06 | 607 | 219 | 16 | 39147351 |
| Pubmed | Rescue of DeltaF508-CFTR by the SGK1/Nedd4-2 signaling pathway. | 2.44e-06 | 5 | 219 | 3 | 19617352 | |
| Pubmed | IFT140 MCC ZZEF1 BCR ZNF461 VPS52 EML5 KLHL21 CDC16 ASPM ADAM17 NUP107 RPP38 BEND3 XIAP CHD9 CHD8 OPA1 CHD5 SDF4 DHX34 TOP2A | 2.59e-06 | 1116 | 219 | 22 | 31753913 | |
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 19259974 | ||
| Pubmed | 2.63e-06 | 35 | 219 | 5 | 24515614 | ||
| Pubmed | IQGAP2 MAP6 USP9X CKAP5 MCC BCR NEDD4 DST ARC LRFN1 NEDD4L MINK1 UBR4 CHD8 OPA1 STRIP1 CASK HOOK3 AKAP9 OTUD4 | 3.50e-06 | 963 | 219 | 20 | 28671696 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.78e-06 | 363 | 219 | 12 | 14691545 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | CCDC8 USP9X MCC NEB BCR DST GRK3 OXSR1 BEND3 CCND2 AKAP9 SDF4 EIF3A | 4.14e-06 | 432 | 219 | 13 | 23455922 |
| Pubmed | ILDR2 IQGAP2 MAP6 USP9X CKAP5 NARS1 BCR DST MTMR2 USP4 FGG DNAH6 PITPNM2 NEDD4L MINK1 SHROOM2 OPA1 STRIP1 CASK NHSL1 SND1 OTUD4 EIF3A ALDH7A1 PRPS1 | 4.41e-06 | 1431 | 219 | 25 | 37142655 | |
| Pubmed | Impact of Key Nicotinic AChR Subunits on Post-Stroke Pneumococcal Pneumonia. | 4.86e-06 | 6 | 219 | 3 | 32481512 | |
| Pubmed | MAGEA10 PFKFB2 PFKFB3 NEB DST STARD9 KLHL21 FGG ZNF670 DNAAF2 ZNF665 NBPF9 OTUD4 ALPK2 | 5.40e-06 | 513 | 219 | 14 | 25798074 | |
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 5.50e-06 | 19 | 219 | 4 | 17373692 | |
| Pubmed | IFT140 SPAST ZZEF1 BCR DST KLHL21 OXSR1 SEMA6C PITPNM2 CHD8 ABCA5 CHD5 SLIT3 DHX34 | 7.64e-06 | 529 | 219 | 14 | 14621295 | |
| Pubmed | 8.46e-06 | 7 | 219 | 3 | 20231857 | ||
| Pubmed | 8.46e-06 | 7 | 219 | 3 | 15896703 | ||
| Pubmed | USP9X CKAP5 CAPN8 DST NF2 ANK1 CHD8 PARP14 LARS2 TOP2A ALPK2 | 9.42e-06 | 332 | 219 | 11 | 37433992 | |
| Pubmed | ZZEF1 BCR ITGB3 FAM111B DST BUB1B YTHDF2 MINK1 CHD8 RSPRY1 CEMIP AACS SLTM AP4B1 DHX34 | 1.82e-05 | 650 | 219 | 15 | 38777146 | |
| Pubmed | 2.01e-05 | 9 | 219 | 3 | 21074528 | ||
| Pubmed | 2.86e-05 | 10 | 219 | 3 | 19584108 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCDC8 SPAST CKAP5 PFKFB2 BCR NEDD4 DST STARD9 BUB1B NHS YTHDF2 NEDD4L MINK1 XIAP NHSL1 AKAP9 PRKAA2 | 3.65e-05 | 861 | 219 | 17 | 36931259 |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 15466011 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19452222 | ||
| Pubmed | Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain. | 3.95e-05 | 2 | 219 | 2 | 20937909 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 18077337 | ||
| Pubmed | Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport. | 3.95e-05 | 2 | 219 | 2 | 19147495 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 12427743 | ||
| Pubmed | Deletion of nicotinic acetylcholine receptor alpha9 in mice resulted in altered bone structure. | 3.95e-05 | 2 | 219 | 2 | 30414510 | |
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 3.95e-05 | 2 | 219 | 2 | 28978442 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 34536344 | ||
| Pubmed | Physiological Functions of the Ubiquitin Ligases Nedd4-1 and Nedd4-2. | 3.95e-05 | 2 | 219 | 2 | 37962894 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27349288 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 30274773 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38813509 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 23262292 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 17991424 | ||
| Pubmed | Down-regulating destruction: phosphorylation regulates the E3 ubiquitin ligase Nedd4-2. | 3.95e-05 | 2 | 219 | 2 | 19602703 | |
| Pubmed | Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. | 3.95e-05 | 2 | 219 | 2 | 14595111 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 12781587 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 17604274 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 28983232 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 21789999 | ||
| Pubmed | The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. | 3.95e-05 | 2 | 219 | 2 | 8756344 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 16497727 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 15531379 | ||
| Pubmed | Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. | 3.95e-05 | 2 | 219 | 2 | 11245921 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 28223528 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19896235 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 15937072 | ||
| Pubmed | A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+ channel. | 3.95e-05 | 2 | 219 | 2 | 11149908 | |
| Pubmed | Nicotinic acetylcholine receptors regulate vestibular afferent gain and activation timing. | 3.95e-05 | 2 | 219 | 2 | 27718229 | |
| Pubmed | Dietary sodium modulates nephropathy in Nedd4-2-deficient mice. | 3.95e-05 | 2 | 219 | 2 | 31802037 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19122172 | ||
| Pubmed | A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. | 3.95e-05 | 2 | 219 | 2 | 11752216 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19166271 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38491008 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 1339443 | ||
| Pubmed | Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA. | 3.95e-05 | 2 | 219 | 2 | 22774872 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 30006345 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27317434 | ||
| Pubmed | Characterization of HA-tagged α9 and α10 nAChRs in the mouse cochlea. | 3.95e-05 | 2 | 219 | 2 | 33311584 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 15331593 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 11502596 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27109789 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38777955 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 37162556 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 37451424 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 10747940 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 8814283 | ||
| Pubmed | APOBEC3G ubiquitination by Nedd4-1 favors its packaging into HIV-1 particles. | 3.95e-05 | 2 | 219 | 2 | 15581898 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 31817275 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38738939 | ||
| Pubmed | Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. | 3.95e-05 | 2 | 219 | 2 | 12519745 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CKAP5 MCC BCR PTPRM AGL MTMR2 PYGL OXSR1 PLD2 MPO UBR4 OPA1 CASK PTPDC1 MTMR6 PRKAA2 EIF3A PRPS1 | 5.05e-05 | 974 | 219 | 18 | 28675297 |
| Pubmed | 5.20e-05 | 12 | 219 | 3 | 20584212 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 5.42e-05 | 33 | 219 | 4 | 22357600 | |
| Pubmed | CAPN12 USP9X NEDD4 CAPN8 MTMR2 USP4 OXSR1 DNAH10 XIAP PLA2G4E CCND2 GCNT7 MTMR6 PLA2G4B PRPS1 | 6.79e-05 | 730 | 219 | 15 | 34857952 | |
| Pubmed | 7.15e-05 | 277 | 219 | 9 | 30745168 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 7.98e-05 | 281 | 219 | 9 | 28706196 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZZEF1 BCR DST NF2 KLHL21 ARC GNA12 SEMA6C PITPNM2 LRFN1 UBR4 CHD8 LARS2 NHSL1 SND1 PLA2G4B CHD5 SDF4 DHX34 | 8.09e-05 | 1105 | 219 | 19 | 35748872 |
| Pubmed | 8.52e-05 | 14 | 219 | 3 | 19059502 | ||
| Pubmed | 8.52e-05 | 14 | 219 | 3 | 29183995 | ||
| Pubmed | 1.18e-04 | 3 | 219 | 2 | 18498246 | ||
| Pubmed | Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. | 1.18e-04 | 3 | 219 | 2 | 21852580 | |
| Pubmed | 1.18e-04 | 3 | 219 | 2 | 19111588 | ||
| Pubmed | 1.18e-04 | 3 | 219 | 2 | 14623077 | ||
| Pubmed | 1.18e-04 | 3 | 219 | 2 | 29018331 | ||
| Cytoband | 19p13.2 | ZNF136 ZNF627 ZNF878 ZNF844 ZNF560 ZNF563 ZNF20 ZNF788P ZNF439 | 1.72e-06 | 229 | 218 | 9 | 19p13.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | ZNF136 ZNF627 PDE4C ZNF878 ZNF556 ZNF844 ZNF560 ZNF563 ZNF20 ZNF788P FUT5 FUT6 ZNF439 ZNF554 | 3.20e-05 | 797 | 218 | 14 | chr19p13 |
| Cytoband | 1p36.31 | 3.70e-05 | 14 | 218 | 3 | 1p36.31 | |
| Cytoband | 19q13.41 | 5.36e-04 | 78 | 218 | 4 | 19q13.41 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF136 ZNF627 ZNF613 ZNF461 ZNF878 ZNF556 ZNF615 ZNF649 ZNF844 ZNF560 ZNF670 ZNF563 ZNF12 ZNF20 ZNF713 ZNF788P ZNF665 ZNF382 RBAK ZNF727 ZNF75A ZNF350 ZNF439 ZNF583 ZNF554 ZNF124 | 1.58e-09 | 718 | 164 | 26 | 28 |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 2.91e-06 | 4 | 164 | 3 | 1077 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.09e-05 | 16 | 164 | 4 | 173 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SPAST USP9X CKAP5 ZZEF1 NEDD4 MGAT5 DST STXBP3 PTPRM CDC16 BUB1B ADAM17 OXSR1 CHD9 LARS2 OPA1 CASK CEMIP PCF11 AKAP9 OTUD4 EIF3A TOP2A | 7.27e-07 | 856 | 216 | 23 | M4500 |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP | 5.40e-06 | 195 | 216 | 10 | M8421 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN | IFT140 ITGB3 PYGL SPSB4 ESPN PPFIBP2 PARP14 DARS2 ZNF12 OASL | 6.75e-06 | 200 | 216 | 10 | M5975 |
| Coexpression | WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION | 1.96e-05 | 20 | 216 | 4 | M11268 | |
| Coexpression | OKAWA_NEUROBLASTOMA_1P36_31_DELETION | 2.92e-05 | 22 | 216 | 4 | M4786 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | USP9X CKAP5 NEDD4 MGAT5 DST BUB1B OXSR1 CHD9 LARS2 OPA1 CASK CEMIP AKAP9 TOP2A | 3.57e-05 | 466 | 216 | 14 | M13522 |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 4.48e-05 | 200 | 216 | 9 | M5617 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP | 4.48e-05 | 200 | 216 | 9 | M4332 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | PDE4C SPAST MAP6 SLC6A17 NEB CHRNA4 MGAT5 GRK3 ERAP2 ENOX1 ANK1 NEDD4L SLC6A15 SHROOM2 STRIP1 CASK CEMIP MTMR6 AKAP9 CHD5 PRKAA2 OTUD4 CXADR | 4.64e-05 | 1106 | 216 | 23 | M39071 |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 5.96e-05 | 161 | 216 | 8 | M40214 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SPAST USP9X MCC APOBEC3G PFKFB2 NFU1 RYR3 NOD1 MGAT5 GRK3 ERAP2 CDC16 USP4 OXSR1 MPV17 RPP38 NDST2 CHD9 OPA1 CCND2 ZNF713 AACS OTUD4 ZNF124 | 7.04e-05 | 1215 | 216 | 24 | M41122 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2 | IL12B N4BP2L1 ETV6 PFKFB3 GRK3 STXBP3 EML5 PIK3CB RAB30 ARC PYGL PLD2 MVP PPFIBP2 CASK SDF4 | 3.59e-06 | 403 | 214 | 16 | GSM605834_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | IL12B N4BP2L1 CYP51A1 ETV6 PFKFB3 GRK3 STXBP3 EML5 PIK3CB RAB30 ARC PYGL MVP PPFIBP2 CASK SDF4 | 5.70e-06 | 418 | 214 | 16 | GSM605836_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ILDR2 KATNAL2 CKAP5 NEB DST EML5 STARD9 ASPM NHS ENOX1 NEDD4L RPP38 CHD8 OPA1 DNAAF2 PTPDC1 AKAP9 SLTM ASTN1 EIF3A | 1.11e-05 | 654 | 214 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | N4BP2L1 CYP51A1 ETV6 PFKFB3 GRK3 STXBP3 PIK3CB RAB30 ARC PYGL MVP PPFIBP2 CASK SDF4 ALPK2 | 2.08e-05 | 413 | 214 | 15 | GSM538263_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1 | N4BP2L1 CYP51A1 PFKFB3 GRK3 STXBP3 PIK3CB RAB30 ARC PYGL PLD2 MVP PPFIBP2 CASK SDF4 ALPK2 | 2.14e-05 | 414 | 214 | 15 | GSM538262_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | ILDR2 KATNAL2 CKAP5 EML5 ASPM ENOX1 NEDD4L AKAP9 SLTM ASTN1 EIF3A | 2.49e-05 | 232 | 214 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ILDR2 KATNAL2 CKAP5 EML5 ASPM NHS NEDD4L CHD8 LARS2 AKAP9 ASTN1 EIF3A | 5.31e-05 | 298 | 214 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 8.49e-05 | 139 | 214 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang+103+11blo.SLN, MHCIIhi CD11c+ Langerin+ CD103+ CD11b-, Lymph Node, avg-3 | 1.47e-04 | 79 | 214 | 6 | GSM538268_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.61e-04 | 194 | 214 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ILDR2 CFTR RYR3 CAPN8 TDRD6 COL12A1 DNAH10 GLRA3 LAMA2 ASTN1 | 7.01e-09 | 160 | 218 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ILDR2 CFTR RYR3 CAPN8 TDRD6 COL12A1 DNAH10 GLRA3 LAMA2 ASTN1 | 7.01e-09 | 160 | 218 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.85e-08 | 200 | 218 | 10 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.75e-07 | 187 | 218 | 9 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-07 | 188 | 218 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.10e-07 | 189 | 218 | 9 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 5.57e-07 | 196 | 218 | 9 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 6.06e-07 | 198 | 218 | 9 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 157 | 218 | 8 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 175 | 218 | 8 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-06 | 176 | 218 | 8 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-06 | 176 | 218 | 8 | 941e8724b6f680719ef2a4f190f943b205bb9e78 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-06 | 179 | 218 | 8 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-06 | 182 | 218 | 8 | 818b5155ec81f0059048d6070a108116ecd72e3c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.45e-06 | 183 | 218 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 187 | 218 | 8 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.21e-06 | 188 | 218 | 8 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.38e-06 | 189 | 218 | 8 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.38e-06 | 189 | 218 | 8 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 4.55e-06 | 190 | 218 | 8 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.92e-06 | 192 | 218 | 8 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-06 | 196 | 218 | 8 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 5.72e-06 | 196 | 218 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.94e-06 | 197 | 218 | 8 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.17e-06 | 198 | 218 | 8 | 9b1a58fcf818f9c4ae57bbe99655f0a64fe87df7 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 6.40e-06 | 199 | 218 | 8 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 6.40e-06 | 199 | 218 | 8 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 6.64e-06 | 200 | 218 | 8 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 200 | 218 | 8 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-05 | 159 | 218 | 7 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-05 | 159 | 218 | 7 | 0fbfdb18b7ed4bde077add13f2b3636e144b254f | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 159 | 218 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 159 | 218 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 160 | 218 | 7 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 160 | 218 | 7 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-05 | 163 | 218 | 7 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 163 | 218 | 7 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 164 | 218 | 7 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 164 | 218 | 7 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 165 | 218 | 7 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 168 | 218 | 7 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 168 | 218 | 7 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.10e-05 | 170 | 218 | 7 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-05 | 171 | 218 | 7 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-05 | 171 | 218 | 7 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.44e-05 | 174 | 218 | 7 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 175 | 218 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 175 | 218 | 7 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 176 | 218 | 7 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-05 | 177 | 218 | 7 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 177 | 218 | 7 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-05 | 179 | 218 | 7 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 179 | 218 | 7 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 181 | 218 | 7 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-05 | 183 | 218 | 7 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 3.36e-05 | 183 | 218 | 7 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 183 | 218 | 7 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 3.48e-05 | 184 | 218 | 7 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 3.48e-05 | 184 | 218 | 7 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 3.48e-05 | 184 | 218 | 7 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 185 | 218 | 7 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 3.73e-05 | 186 | 218 | 7 | 9ff3c30b1728707bb8f9422941333fe3b2c430f4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-05 | 188 | 218 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 189 | 218 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.13e-05 | 189 | 218 | 7 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 189 | 218 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-05 | 189 | 218 | 7 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-05 | 190 | 218 | 7 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.27e-05 | 190 | 218 | 7 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.27e-05 | 190 | 218 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.41e-05 | 191 | 218 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 218 | 7 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 4.56e-05 | 192 | 218 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 4.56e-05 | 192 | 218 | 7 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-05 | 193 | 218 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-05 | 193 | 218 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.71e-05 | 193 | 218 | 7 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 194 | 218 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 194 | 218 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.87e-05 | 194 | 218 | 7 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 195 | 218 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 196 | 218 | 7 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 196 | 218 | 7 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-05 | 197 | 218 | 7 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | mild-Platelet|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.54e-05 | 198 | 218 | 7 | 8bb79e749caffb56bee2941594ef2bdc17daba30 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.54e-05 | 198 | 218 | 7 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.72e-05 | 199 | 218 | 7 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.72e-05 | 199 | 218 | 7 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 5.72e-05 | 199 | 218 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.72e-05 | 199 | 218 | 7 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 5.90e-05 | 200 | 218 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.90e-05 | 200 | 218 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.90e-05 | 200 | 218 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 5.90e-05 | 200 | 218 | 7 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.90e-05 | 200 | 218 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 5.90e-05 | 200 | 218 | 7 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.90e-05 | 200 | 218 | 7 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| Drug | Nicotine | 1.19e-07 | 6 | 217 | 4 | DB00184 | |
| Drug | 2-MP | 5.45e-07 | 8 | 217 | 4 | CID003015569 | |
| Drug | Galantamine | 5.45e-07 | 8 | 217 | 4 | DB00674 | |
| Drug | beta-erythroidine | 7.83e-07 | 19 | 217 | 5 | CID000010074 | |
| Drug | PNU-120596 | 7.83e-07 | 19 | 217 | 5 | CID000311434 | |
| Drug | Dichloride, Alcuronium | 1.04e-06 | 20 | 217 | 5 | CID003032788 | |
| Drug | meproadifen | 1.35e-06 | 21 | 217 | 5 | CID000189752 | |
| Drug | suberyldicholine | 1.73e-06 | 22 | 217 | 5 | CID000123989 | |
| Drug | Dns-C6-Cho | 2.51e-06 | 11 | 217 | 4 | CID000124728 | |
| Drug | AC1L9NC9 | 2.51e-06 | 11 | 217 | 4 | CID000449642 | |
| Drug | dihydronereistoxin | 2.51e-06 | 11 | 217 | 4 | CID000121232 | |
| Drug | LJP 1082 | 2.51e-06 | 11 | 217 | 4 | CID003037609 | |
| Drug | bipinnatin-B | 2.51e-06 | 11 | 217 | 4 | CID000127363 | |
| Drug | succinylcholine | 2.54e-06 | 64 | 217 | 7 | CID000005314 | |
| Drug | anabaseine | 2.75e-06 | 24 | 217 | 5 | CID000018985 | |
| Drug | AC1L9P8C | 3.74e-06 | 12 | 217 | 4 | CID000450864 | |
| Drug | SureCN373116 | 3.74e-06 | 12 | 217 | 4 | CID010085732 | |
| Drug | nereistoxin | 5.36e-06 | 13 | 217 | 4 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 5.36e-06 | 13 | 217 | 4 | CID004392675 | |
| Drug | C-toxiferine-I | 5.36e-06 | 13 | 217 | 4 | CID005089093 | |
| Drug | bipinnatin-A | 5.36e-06 | 13 | 217 | 4 | CID000196603 | |
| Drug | bipinnatin-C | 5.36e-06 | 13 | 217 | 4 | CID000129977 | |
| Drug | Chlorpyrifos | USP9X CYP51A1 PFKFB3 BCR CHRNA7 GRK3 ASPM ARC GNA12 CHRNA10 YTHDF2 MPO MPV17 LRFN1 NEDD4L CHRNA9 XIAP CCND2 AKAP9 ABCA5 CHD5 SLIT3 EIF3A TOP2A ALDH7A1 | 5.45e-06 | 960 | 217 | 25 | ctd:D004390 |
| Drug | 2,3-dichlorooctafluorobutane | 7.45e-06 | 14 | 217 | 4 | CID000078982 | |
| Drug | LNF 209 | 7.45e-06 | 14 | 217 | 4 | CID000132666 | |
| Drug | vecuronium | 8.81e-06 | 30 | 217 | 5 | CID000039764 | |
| Drug | sodium chloride | IL12B MANBA C1GALT1 PFKFB1 PFKFB2 PFKFB3 ITGB3 MGAT5 DST GRK3 PTPRM PIK3CB AGL PYGL FGG MPO POMT2 MRC1 COL12A1 LPO FUT5 FUT6 PRPS1 | 9.51e-06 | 865 | 217 | 23 | CID000000206 |
| Drug | anatoxin-a hydrochloride | 1.01e-05 | 15 | 217 | 4 | CID000135265 | |
| Drug | SAD-128 | 1.01e-05 | 15 | 217 | 4 | CID000162008 | |
| Drug | Thr-Ala | 1.01e-05 | 15 | 217 | 4 | CID006427021 | |
| Drug | N-methylcytisine | 1.01e-05 | 15 | 217 | 4 | CID000234566 | |
| Drug | aa373 | 1.01e-05 | 15 | 217 | 4 | CID000191672 | |
| Drug | (-)-pictamine | 1.01e-05 | 15 | 217 | 4 | CID006918623 | |
| Drug | (-)-lepadin B | 1.01e-05 | 15 | 217 | 4 | CID006918624 | |
| Drug | UB-165 | 1.01e-05 | 15 | 217 | 4 | CID004694339 | |
| Drug | M3/M4 | 1.23e-05 | 32 | 217 | 5 | CID000486507 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 1.34e-05 | 16 | 217 | 4 | CID000123866 | |
| Drug | AC1L2SVN | 1.34e-05 | 16 | 217 | 4 | CID000127922 | |
| Drug | benzoquinonium | 1.34e-05 | 16 | 217 | 4 | CID000009393 | |
| Drug | PNU-282,987 | 1.34e-05 | 16 | 217 | 4 | CID004655349 | |
| Drug | decamethonium | 1.43e-05 | 33 | 217 | 5 | CID000002968 | |
| Drug | Nsc36388 | 1.73e-05 | 17 | 217 | 4 | CID000014954 | |
| Drug | EPTC | 1.93e-05 | 35 | 217 | 5 | CID000012968 | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | MTMR2 ADAM17 POMT2 MINK1 CEMIP TBC1D13 ZNF20 AKAP9 SND1 ZNF350 | 1.97e-05 | 196 | 217 | 10 | 3233_DN |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A | PDE4C MGAT5 CHRNA10 ANK1 NEDD4L PPFIBP2 MINK1 CHD5 OTUD4 MYB | 2.15e-05 | 198 | 217 | 10 | 2284_UP |
| Drug | AC1L1AO2 | 2.21e-05 | 18 | 217 | 4 | CID000001073 | |
| Drug | AC1O8PVM | 2.21e-05 | 18 | 217 | 4 | CID000004989 | |
| Drug | ABT-594 | 2.21e-05 | 18 | 217 | 4 | CID003075702 | |
| Drug | AC1LCVGE | 2.21e-05 | 18 | 217 | 4 | CID000656712 | |
| Drug | benzetimide | 2.21e-05 | 18 | 217 | 4 | CID000021846 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.55e-05 | 37 | 217 | 5 | CID000009643 | |
| Drug | AC1L9P88 | 2.78e-05 | 19 | 217 | 4 | CID000450860 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 2.78e-05 | 19 | 217 | 4 | CID000162425 | |
| Drug | isoarecolone | 2.78e-05 | 19 | 217 | 4 | CID000146970 | |
| Drug | perhydrohistrionicotoxin | 2.78e-05 | 19 | 217 | 4 | CID000107881 | |
| Drug | glipentide | 2.91e-05 | 7 | 217 | 3 | CID000065779 | |
| Drug | NSC-293162 | 2.92e-05 | 38 | 217 | 5 | CID000004675 | |
| Drug | AC1Q5X7V | 3.45e-05 | 20 | 217 | 4 | CID000050190 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 3.45e-05 | 20 | 217 | 4 | CID000001962 | |
| Drug | carbaryl | 3.95e-05 | 66 | 217 | 6 | CID000006129 | |
| Drug | dinotefuran | 4.23e-05 | 21 | 217 | 4 | CID000197701 | |
| Drug | methacholine | CHRNA4 CHRNA7 NOD1 GRK3 PTPRM CHRNA10 MPO CHRNA9 SLIT3 ALDH7A1 | 4.68e-05 | 217 | 217 | 10 | CID000001993 |
| Drug | AR-R17779 | 5.13e-05 | 22 | 217 | 4 | CID005310971 | |
| Drug | histrionicotoxin | 5.13e-05 | 22 | 217 | 4 | CID005282247 | |
| Drug | clothianidin | 5.13e-05 | 22 | 217 | 4 | CID000213027 | |
| Drug | halothane | CYP51A1 C1GALT1 ZZEF1 CHRNA4 CHRNA7 RYR3 NF2 CHRNA10 CACNA1D CACNA1S CHRNA9 GLRA3 | 5.18e-05 | 314 | 217 | 12 | CID000003562 |
| Drug | amiloride | CFTR CHRNA4 CHRNA7 RYR3 NEDD4 CHRNA10 CACNA1D CACNA1S NEDD4L CHRNA9 GLRA3 TAS1R1 | 5.34e-05 | 315 | 217 | 12 | CID000016230 |
| Drug | gallamin | 5.38e-05 | 43 | 217 | 5 | CID000067425 | |
| Drug | AC1L3BL8 | 6.16e-05 | 23 | 217 | 4 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 6.16e-05 | 23 | 217 | 4 | CID000133011 | |
| Drug | alpha-conotoxin SI | 6.16e-05 | 23 | 217 | 4 | CID000163979 | |
| Drug | CID6325740 | 6.16e-05 | 23 | 217 | 4 | CID006325740 | |
| Drug | ABT-418 | 6.16e-05 | 23 | 217 | 4 | CID000119380 | |
| Drug | Skpymrfamide | 6.16e-05 | 23 | 217 | 4 | CID000132661 | |
| Drug | 3H-diazirine | 6.73e-05 | 45 | 217 | 5 | CID000078958 | |
| Drug | procyclidine | 7.34e-05 | 24 | 217 | 4 | CID000004919 | |
| Drug | AC1L2IZE | 7.34e-05 | 24 | 217 | 4 | CID000072928 | |
| Drug | intruder | 7.34e-05 | 24 | 217 | 4 | CID000213021 | |
| Drug | NSC100058 | 7.55e-05 | 74 | 217 | 6 | CID000003449 | |
| Drug | nicardipine | 7.79e-05 | 145 | 217 | 8 | CID000004473 | |
| Drug | propranolol | IL12B CYP51A1 CHRNA4 CHRNA7 RYR3 GRK3 PYGL PLD2 CHRNA10 CACNA1D CACNA1S CHRNA9 PLA2G4E ALDH7A1 | 7.79e-05 | 434 | 217 | 14 | CID000004946 |
| Drug | anabasine | 8.68e-05 | 25 | 217 | 4 | CID000002181 | |
| Drug | varenicline | 8.68e-05 | 25 | 217 | 4 | CID000170361 | |
| Drug | PrBCM | 8.68e-05 | 25 | 217 | 4 | CID000037396 | |
| Drug | pempidine | 8.68e-05 | 25 | 217 | 4 | CID000006603 | |
| Drug | eriochrome cyanin | 9.04e-05 | 2 | 217 | 2 | CID000075762 | |
| Drug | Varenicline | 9.04e-05 | 2 | 217 | 2 | DB01273 | |
| Drug | RC39II | 9.04e-05 | 2 | 217 | 2 | CID005743561 | |
| Drug | propofol | 9.47e-05 | 191 | 217 | 9 | CID000004943 | |
| Drug | benzquinamide | 1.02e-04 | 26 | 217 | 4 | CID000002342 | |
| Drug | beta-eudesmol | 1.02e-04 | 26 | 217 | 4 | CID000091457 | |
| Drug | curarine | 1.02e-04 | 26 | 217 | 4 | CID000198004 | |
| Drug | imidazolidine | 1.02e-04 | 26 | 217 | 4 | CID000449488 | |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.07e-04 | 194 | 217 | 9 | 954_UP | |
| Drug | procaine | 1.13e-04 | 153 | 217 | 8 | CID000004914 | |
| Drug | imidazole | 1.16e-04 | 242 | 217 | 10 | CID000000795 | |
| Drug | methylcarbamylcholine | 1.19e-04 | 27 | 217 | 4 | CID000004136 | |
| Drug | BHAC | 1.19e-04 | 27 | 217 | 4 | CID000003228 | |
| Drug | nornicotine | 1.19e-04 | 27 | 217 | 4 | CID000000412 | |
| Drug | mitiglinide | 1.19e-04 | 27 | 217 | 4 | CID000121891 | |
| Disease | Schizophrenia | IL12B MAP6 ITGB3 CHRNA4 CHRNA7 NTNG2 EML5 PIK3CB ARC OXSR1 ALOX12 LAMA2 LARS2 OPA1 CCND2 PLA2G4B SLIT3 SDF4 ARHGAP18 | 2.16e-05 | 883 | 211 | 19 | C0036341 |
| Disease | Hereditary hearing loss and deafness | 9.06e-05 | 146 | 211 | 7 | cv:C0236038 | |
| Disease | multiple sclerosis | IL12B ZNF627 MANBA ETV6 C1GALT1 SOX8 MGAT5 ACSF3 MPO ESPN PITPNM2 MINK1 ALPK2 MYB | 1.05e-04 | 594 | 211 | 14 | MONDO_0005301 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.25e-04 | 36 | 211 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.02e-04 | 4 | 211 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | alpha-(1;3)-fucosyltransferase 5 measurement | 3.02e-04 | 4 | 211 | 2 | EFO_0021979 | |
| Disease | malignant pleural mesothelioma (is_implicated_in) | 3.02e-04 | 4 | 211 | 2 | DOID:7474 (is_implicated_in) | |
| Disease | executive function measurement, cognitive function measurement | 3.02e-04 | 4 | 211 | 2 | EFO_0008354, EFO_0009332 | |
| Disease | Liddle syndrome (implicated_via_orthology) | 3.02e-04 | 4 | 211 | 2 | DOID:0050477 (implicated_via_orthology) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 3.21e-04 | 19 | 211 | 3 | DOID:1591 (biomarker_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 5.02e-04 | 5 | 211 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | lung disease (is_implicated_in) | 5.02e-04 | 22 | 211 | 3 | DOID:850 (is_implicated_in) | |
| Disease | lactoperoxidase measurement | 7.49e-04 | 6 | 211 | 2 | EFO_0020525 | |
| Disease | asthma (is_implicated_in) | 9.61e-04 | 157 | 211 | 6 | DOID:2841 (is_implicated_in) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.04e-03 | 7 | 211 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 1.04e-03 | 7 | 211 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 1.04e-03 | 7 | 211 | 2 | EFO_0021853 | |
| Disease | alpha-(1,3)-fucosyltransferase 5 measurement | 1.04e-03 | 7 | 211 | 2 | EFO_0020136 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.05e-03 | 107 | 211 | 5 | DOID:6000 (biomarker_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.09e-03 | 63 | 211 | 4 | DOID:3083 (is_implicated_in) | |
| Disease | treatment-resistant hypertension | 1.14e-03 | 109 | 211 | 5 | EFO_1002006 | |
| Disease | respiratory failure, COVID-19 | 1.15e-03 | 29 | 211 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | Retinal Dystrophies | 1.39e-03 | 8 | 211 | 2 | C0854723 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.45e-03 | 68 | 211 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 1.68e-03 | 33 | 211 | 3 | EFO_0007905 | |
| Disease | Manic Disorder | 1.70e-03 | 71 | 211 | 4 | C0024713 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.77e-03 | 9 | 211 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | SPAST NEDD4 NF2 PIK3CB NHS PLD2 ANK1 UBR4 LAMA2 SHROOM2 HOOK3 AKAP9 CHD5 PRKAA2 ZNF75A TOP2A PRPS1 | 1.94e-03 | 1074 | 211 | 17 | C0006142 |
| Disease | Keloid | 1.99e-03 | 35 | 211 | 3 | C0022548 | |
| Disease | protein intake measurement | 2.21e-03 | 10 | 211 | 2 | EFO_0010810 | |
| Disease | Manic | 2.40e-03 | 78 | 211 | 4 | C0338831 | |
| Disease | Bipolar Disorder | PFKFB3 BCR CHRNA7 NEDD4 NTNG2 GRK3 STARD9 ALOX12 CACNA1D LARS2 | 2.42e-03 | 477 | 211 | 10 | C0005586 |
| Disease | Depression, Bipolar | 2.51e-03 | 79 | 211 | 4 | C0005587 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 2.68e-03 | 11 | 211 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Macrocephaly | 2.68e-03 | 11 | 211 | 2 | C0221355 | |
| Disease | primary biliary cirrhosis | 2.73e-03 | 133 | 211 | 5 | EFO_1001486 | |
| Disease | Nonsyndromic Deafness | 2.75e-03 | 81 | 211 | 4 | C3711374 | |
| Disease | Autistic Disorder | 2.84e-03 | 261 | 211 | 7 | C0004352 | |
| Disease | Congenital muscular dystrophy | 3.20e-03 | 12 | 211 | 2 | cv:C0699743 | |
| Disease | Congenital myopathy (disorder) | 3.20e-03 | 12 | 211 | 2 | C0270960 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 3.60e-03 | 43 | 211 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | diet measurement | ILDR2 KATNAL2 CCDC8 PFKFB3 CAPN8 RASIP1 NTNG2 DST MUC17 CDC16 MTMR2 KLB LAMA2 LARS2 SND1 UBR3 | 3.76e-03 | 1049 | 211 | 16 | EFO_0008111 |
| Disease | leukemia (is_implicated_in) | 3.77e-03 | 13 | 211 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | serum IgG glycosylation measurement | 4.62e-03 | 523 | 211 | 10 | EFO_0005193 | |
| Disease | forced expiratory volume | TDRD9 CKAP5 ETV6 C1GALT1 DST AGL CACNA1D STON1 ANK1 XIAP LARS2 PTPDC1 OTUD4 | 4.66e-03 | 789 | 211 | 13 | EFO_0004314 |
| Disease | Colorectal Carcinoma | CFTR MCC BUB1B MPO ZNF560 HPS3 CCND2 AKAP9 ABCA5 CHD5 SDF4 PRPS1 | 4.87e-03 | 702 | 211 | 12 | C0009402 |
| Disease | response to platinum based chemotherapy, magnesium measurement | 5.03e-03 | 15 | 211 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | mean reticulocyte volume | IQGAP2 ETV6 PFKFB1 NEB NOD1 ACSF3 OXSR1 STON1 ANK1 BEND3 HPS3 OTUD4 MYB | 5.17e-03 | 799 | 211 | 13 | EFO_0010701 |
| Disease | Mitochondrial Diseases | 5.21e-03 | 49 | 211 | 3 | C0751651 | |
| Disease | Urticaria | 5.72e-03 | 16 | 211 | 2 | C0042109 | |
| Disease | alpha fetoprotein measurement | 5.84e-03 | 100 | 211 | 4 | EFO_0010583 | |
| Disease | serum gamma-glutamyl transferase measurement | PDE4C IQGAP2 MCC NARS1 RASIP1 NTNG2 PTPRM KLB NEDD4L CHD9 SLC6A15 OASL FUT6 ALPK2 | 6.33e-03 | 914 | 211 | 14 | EFO_0004532 |
| Disease | muscular dystrophy (is_implicated_in) | 6.45e-03 | 17 | 211 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | glycochenodeoxycholate measurement | 6.45e-03 | 17 | 211 | 2 | EFO_0010490 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KNVDTYNPWDRLSVA | 1196 | Q8WWZ7 | |
| EDYKLFWVAPRNSAE | 776 | O60566 | |
| VWRPDIVLYNKADAQ | 111 | Q9GZZ6 | |
| LGVPYEQWKALNEID | 316 | P16118 | |
| AESLGVPYEQWKILN | 311 | O60825 | |
| ELIWRPDIVLYNNAD | 116 | P43681 | |
| VSEPWLEERKAYINT | 2976 | Q99996 | |
| YKNFPLVISERWQQE | 506 | P35626 | |
| WIRKYNPDTLFQDES | 1551 | Q9HCK8 | |
| VLENLKDRWYQADSP | 196 | Q9BRK5 | |
| KDRWYQADSPPADLL | 201 | Q9BRK5 | |
| RKNLDPYEQWSDQEI | 1301 | P13569 | |
| QEENVDPDYWEKLLR | 1311 | Q8TDI0 | |
| PEWFKGSRLNYAENL | 91 | Q86V21 | |
| QPQYAWLKELGLREE | 36 | P49419 | |
| KTRVYRDTAEPNWNE | 946 | P11274 | |
| DILLEESKEYRPGNW | 1216 | Q86TB3 | |
| IPFWKLDLDQDYRVT | 266 | Q9HC16 | |
| DIREHEWFKQDLPSY | 261 | P54646 | |
| IVRDVQEFIDNPKWY | 201 | Q9Y276 | |
| LSSPLRADQYWNEVA | 1531 | P16157 | |
| EPLDQFLWRKRDLYQ | 296 | Q7LC44 | |
| VPNRQLTADYFEKTW | 621 | Q9Y6B7 | |
| GRPAAEYWNSQKDIL | 81 | P04440 | |
| ELLYDPEKDNRDQAW | 136 | Q56P03 | |
| LVWRPDIVLYNKADD | 111 | Q9UGM1 | |
| RELKEWARNVLAPYA | 531 | Q4G176 | |
| YWTNPQFKIRLDEVD | 381 | A6NHC0 | |
| SETPNLYLERQWEKL | 2831 | Q96M86 | |
| IDRYEPWDQAALAKV | 3041 | Q96M86 | |
| YEAAVALRDISWQQP | 366 | Q9BZG8 | |
| SYLTKNDNWLVRHPD | 971 | Q8WUJ3 | |
| ILNRLLWNPDIAAEY | 851 | Q8IZT6 | |
| PNKQVQRRLWLEYED | 881 | O14525 | |
| QIWKPDILLYNSADE | 106 | P36544 | |
| LWDLEQQELPANYRH | 941 | Q5U651 | |
| SFEEYLKRLENPQEW | 86 | Q01804 | |
| PEWLREIEQYASNKV | 101 | Q15771 | |
| PKTYWTRELANDELI | 106 | P29762 | |
| FLRQKWNDPRLAYSE | 96 | O75311 | |
| EELPREYLGANWTLE | 476 | P57740 | |
| SALPWSINRDDYELQ | 6 | O95747 | |
| LYPRAKNDRVWTLEF | 621 | Q5T5X7 | |
| YTDNSIKPQELLEWE | 126 | P30279 | |
| KWAENEFSLRPIDSN | 71 | P41212 | |
| TVYEALNHPWLKERD | 266 | O14936 | |
| AALYLAEWAIENPAA | 141 | P0C5J1 | |
| ILYRDPENGWSKLTE | 336 | Q9H511 | |
| EPRKLLTQDWVQENY | 266 | P43363 | |
| ERETQYQKDFRAWPL | 151 | Q96JE9 | |
| YNSLRWILENDPTEL | 1101 | P46934 | |
| EELDWNLLKPDIYAT | 126 | Q9UMS0 | |
| WRAKNPYEEADHNSL | 201 | Q09328 | |
| DLNPLWYKLRFSAQD | 551 | Q9NVR5 | |
| RLQGWQLIDLAEEYK | 121 | Q9Y217 | |
| DALQALIDWLYRVEP | 6821 | Q03001 | |
| DLDLSYNNLEALPWE | 166 | Q9P244 | |
| GYDESKLAPWQRQVI | 831 | B1AK53 | |
| YTFPANRWLDKNQAD | 781 | Q8IVV2 | |
| DENWIYRAQPRKAVS | 56 | Q5SYE7 | |
| DAALYLAEWAIENPA | 106 | Q8N7N1 | |
| SRDIYLHNPNIKWND | 241 | Q8IYT4 | |
| TLEDNREWYQSKIPR | 626 | Q08493 | |
| ANRALARWLPAEYED | 156 | P22079 | |
| KSLNPRWDGERLYQE | 431 | P05164 | |
| SQWPAEYLQRKFEAQ | 401 | Q6P3R8 | |
| EENPYDLDAWSILIR | 26 | Q12996 | |
| QTAEALRLPYEQWKA | 306 | Q16875 | |
| QQLADAYVDLRPWLL | 91 | Q9Y239 | |
| QPESYELWKHRQDLA | 326 | B2RXH2 | |
| RWLDLHSNYIDKLPE | 76 | Q8N456 | |
| PNESWRITKINERYE | 221 | Q13614 | |
| LELGWEALYEQRAEP | 431 | H0YKK7 | |
| NWILERSLDDVEYKP | 151 | P24043 | |
| DDWKVIANYLPNRTD | 61 | P10242 | |
| LANLYEDPEWSQKDL | 341 | P0C869 | |
| RACKYENPARWSEQE | 61 | A2A3K4 | |
| KEITARNEQLDWPYE | 636 | P18054 | |
| KTQRGPLSENWIEEY | 166 | Q9BZ72 | |
| QKIDPAYFDENWLNR | 46 | Q86VS8 | |
| LKNSRQVEVSWEYPD | 246 | P29460 | |
| LAYNWHFEVNDRKDP | 541 | Q14764 | |
| TRWLDDIGLPQYKDQ | 636 | Q8ND30 | |
| FPWNEIRNISYSDKE | 256 | P35240 | |
| YDNRENPISSWNVKR | 336 | Q15646 | |
| PQDYIRLWQELSDSL | 686 | Q8IV76 | |
| LYALDVRVNSLDPAW | 131 | O94913 | |
| RFNLETEWKNNYPRL | 571 | O60313 | |
| EKIERIQNPDLWNSY | 1646 | Q460N5 | |
| LYRDPDWSSKNLEPA | 421 | Q3MJ16 | |
| SAIPYALRVELEDWN | 266 | P02679 | |
| SLSREEPQDIYWLAQ | 31 | Q13042 | |
| LKWNFTTPRDEYIEQ | 1181 | Q14008 | |
| EQRNEFWAPLLEKAY | 171 | Q6ZSI9 | |
| WLRKYNPEQLLQDEG | 1601 | Q3L8U1 | |
| YPNLAEERSRWEKEL | 221 | P23508 | |
| RNWLYLESIFNAPDI | 1106 | Q9C0G6 | |
| EVDVYNPTRNEWDKI | 481 | Q9UJP4 | |
| SDPFAIWQITDRDYK | 2591 | Q99715 | |
| PEQHYWVTLNRLKDA | 311 | Q6ZNI0 | |
| EVKDLYNWLEVEFNP | 386 | Q14152 | |
| VHLYDNWIKDADPRV | 11 | A1L3X0 | |
| WPQLLYKAIDSNAED | 1016 | Q13698 | |
| YAVIPAEKFDLIWNR | 176 | Q5TC12 | |
| EGSLPLQYEWQKLSD | 166 | P78310 | |
| WVERLDFNPDRYLQD | 421 | Q16850 | |
| ARDKLGIPWQYSENE | 111 | Q03113 | |
| HPDYITEKLWRNALE | 251 | P51993 | |
| SPIYDKSAQEWNLEI | 221 | O00462 | |
| VPNDSDRKYLKDWAR | 36 | Q9NU23 | |
| FQEDPEWRALQERYL | 571 | Q6P179 | |
| ARAKWDTANNPLYKE | 761 | P05106 | |
| LREALNWIKLEYNNP | 396 | Q86Z14 | |
| LDNLRWLLSKYDPEE | 176 | Q9NS00 | |
| QELPREKYLTWASRQ | 256 | P01877 | |
| DRIFDISWDLYQPNK | 151 | Q05BV3 | |
| IWPKYSDINDINSVD | 511 | Q05BV3 | |
| SIEPWLKVSNENLDY | 531 | Q6SJ93 | |
| PQLSKADRWREYVSQ | 186 | Q9H0W5 | |
| YDPQAKLQRLQEFWI | 466 | Q14147 | |
| QLRFYWDREPDELNI | 1771 | Q8IVF4 | |
| AYALKEENDSLRWQL | 426 | Q8TC92 | |
| ANYLQSLDWRKEPEI | 1251 | Q96RY7 | |
| KGYLDWITQAEDIDP | 436 | Q01668 | |
| KVNPVQGLASRWDYE | 151 | Q96KJ9 | |
| EEKIFLQWREPTQTY | 496 | P28827 | |
| KLLQYDPSQDQWSVR | 461 | Q3ZCT8 | |
| YLSWLRNKILHNDPE | 1086 | Q8N4C8 | |
| RLSQLYKWQEEDSGP | 4426 | Q685J3 | |
| YEPNDELWIGLNDIK | 416 | P22897 | |
| LEKSLDNGRTWQPYQ | 151 | Q96CW9 | |
| TYRVDDIDWDQNPKS | 316 | Q96J94 | |
| ENSLHPDYITEKLWR | 261 | Q11128 | |
| PDYITEKLWRNALEA | 266 | Q11128 | |
| PVLAIQLKRFDYDWE | 1791 | Q93008 | |
| LIEGLLQYSWPNDKD | 296 | Q6PI48 | |
| EVEDERPAWNSKLQY | 56 | Q9H2J7 | |
| WVKGPRYLLQDDAQA | 71 | Q5T2D2 | |
| RLVTLESWANDPDYL | 271 | Q96DX4 | |
| AVFPEDNLWYRAVIK | 1361 | O60522 | |
| NNPYIIRWSALESED | 26 | P78345 | |
| PYLKETLNSIWNVED | 506 | Q9UKY4 | |
| FPTIYVDSQKENERW | 41 | O43776 | |
| GLAYQKEALVNWDPV | 196 | Q15031 | |
| YRLVHKDFWDNSIPD | 506 | Q8NDG6 | |
| PYANHELKEENRTLW | 921 | Q969F9 | |
| ADLWLLNDLKTNDPY | 946 | Q6T4R5 | |
| EKEPEVLQDSLGRWY | 701 | P0DPF3 | |
| ETENWSPQKSQRRYD | 1176 | Q8IVG5 | |
| DSDSYKRQAAPEIIW | 86 | Q15573 | |
| LVDDNLAPEYQKELW | 246 | Q13576 | |
| RDDPYWSENKKLSLD | 736 | Q9NWH9 | |
| NYDLWLEREVFSKPI | 816 | Q5VSL9 | |
| YQASWKEQRKPLEAR | 876 | Q13796 | |
| WRDYVAPTANLDQKD | 326 | Q7KZF4 | |
| AQDNWAKLQRDYPDA | 116 | P39210 | |
| VSPQTLEAYIRWNKD | 596 | Q9UBP0 | |
| VWAQAARRKLADQYP | 111 | P57073 | |
| ERDWSALQQKYLLEL | 1481 | Q9P2P6 | |
| LLNWLKEYNSGDDLD | 881 | P42338 | |
| PVLQAWLEEAEAAYR | 246 | Q15319 | |
| IDNRLDSKEWPYCSQ | 486 | O00186 | |
| EYNIEPLWRFVNDTK | 146 | P78536 | |
| EWTCLDPAQKTLYRD | 21 | Q9H7R5 | |
| KWLADYLQDNPIETS | 446 | O75094 | |
| EWQFLSPAQKDLYRD | 21 | Q8N8J6 | |
| DVPALDRYWEQVLAL | 461 | Q8N1B4 | |
| DLITYLEQRKEPWNA | 51 | A8MUV8 | |
| WALLDPSQKNLYRDV | 21 | P17024 | |
| NRYWRDKLDTVVEFP | 831 | Q13107 | |
| ANPDWEKFQRKYNLD | 541 | A4D1E1 | |
| EEWALLDPSQKNLYR | 16 | P52737 | |
| YSEEARLKSFQNWPD | 161 | P98170 | |
| DNRDPLSSYNIIAWD | 441 | Q7RTX1 | |
| SAYQAVVWKIDRLPD | 626 | Q9Y6Q2 | |
| WNPEDRSLNVFVKDD | 56 | Q96A44 | |
| RAQSLSKRNLEWDPY | 76 | Q71H61 | |
| RYVDNNRSNWLKSPD | 3271 | Q15413 | |
| EWQQLDPDEKITYRD | 21 | Q9NYW8 | |
| EEWALLNPAQRKLYR | 16 | Q9HAH1 | |
| YLNITKHLEERQNWP | 201 | Q9UBT6 | |
| WDHLTPEQRNLYKDV | 56 | A6NDX5 | |
| EEWALLDPSQKNLYR | 16 | Q7L945 | |
| ENLLKYVNLDAWSRE | 141 | P52849 | |
| VPNKYLTWRSQDVEN | 96 | Q9H3T2 | |
| PDSRWNTYFKDNEVL | 106 | Q9NVG8 | |
| IDDNLKPWLLEVNYS | 376 | Q9BWV7 | |
| NQYPDIWARESLARD | 91 | O75360 | |
| DLYQLNPNAEWVIKS | 646 | Q8N392 | |
| EEWSLLDPSQKNLYR | 16 | Q08AG5 | |
| EWALLDPSQKNLYRD | 26 | Q15973 | |
| EWQLLGAAQKDLYRD | 21 | Q9GZX5 | |
| LKFLYDDNQRVEPEW | 826 | P11388 | |
| EEWALLGPSQKNLYR | 16 | Q8TA94 | |
| QDSRQKAVWPLELAY | 111 | Q3LFD5 | |
| DSEYNPWRKLTQLEE | 1501 | Q6ZT12 | |
| EWQLLGPAQKDLYRD | 21 | Q6PF04 | |
| AINYPNKATRLWNVE | 2946 | O43149 | |
| DEWALLDPSQKNLYR | 36 | Q6ZQV5 | |
| YAEPAVLKWIRENIS | 146 | P60891 | |
| DAEDRPAWNSKLQYI | 56 | Q9H1V8 | |
| FTREEWDQLYPAQKN | 41 | Q8N859 | |
| EWQQLDPEQKITYRD | 21 | P17014 | |
| EEWELLDPTQKALYN | 6 | Q96N20 | |
| WQQLDPAQKALYRDV | 21 | Q96SR6 | |
| AQLWLKRDPKASYDA | 4056 | Q5T4S7 | |
| YAQNIWNVEPSDLKI | 821 | P06737 | |
| ALDVLRDPELNWQAY | 321 | Q5TAA0 | |
| EVDAWLRRAQDKYPA | 496 | Q5TAA0 | |
| YSNLITKDWVQLDRP | 511 | O14939 | |
| PSLREDCQSEDWYKN | 116 | Q96ND8 | |
| KLRSINNYNPKDFDW | 391 | Q9Y5A9 | |
| LSPKRDIYETELSQW | 111 | Q8TAF7 | |
| QEEWTLLDPAQRNLY | 121 | Q96MR9 | |
| EEWALLDPSQKNLYR | 16 | Q9BS34 | |
| EEWALLDPSQKNLYR | 16 | C9JN71 | |
| EEWALLDISQKNLYR | 31 | Q8NDP4 | |
| EWQFLSPAQKDLYRD | 21 | Q9BS31 | |
| QEEWELLEPAQKNLY | 56 | Q86TJ5 | |
| VSEERFYTKWNPEAL | 671 | P35573 | |
| ASEWALKPELARQEY | 481 | P23276 | |
| LYQEWLEGINSPKAR | 421 | Q9UHQ1 | |
| NNYEVIFREPDTRWK | 136 | Q5TBK1 | |
| LQSENLYKSDLEWLR | 2406 | P20929 | |
| LQSDNVYKADLEWLR | 4106 | P20929 | |
| YIDHNSKITQWEDPR | 566 | Q96PU5 |